Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $31.2B |
| FY2017, ended Dec 31, 2017 | $37.4B |
| FY2018, ended Dec 31, 2018 | $37.7B |
| FY2019, ended Dec 31, 2019 | $48.4B |
| FY2020, ended Dec 31, 2020 | $49.9B |
| FY2021, ended Dec 31, 2021 | $69.2B |
| FY2022, ended Dec 31, 2022 | $64.0B |
| FY2023, ended Dec 31, 2023 | $71.9B |
| FY2024, ended Dec 31, 2024 | $81.1B |
| FY2025, ended Dec 31, 2025 | $88.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $81.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $13.6B |
| FY2017, ended Dec 31, 2017 | $14.5B |
| FY2018, ended Dec 31, 2018 | $14.9B |
| FY2019, ended Dec 31, 2019 | $15.5B |
| FY2020, ended Dec 31, 2020 | $15.2B |
| FY2021, ended Dec 31, 2021 | $17.9B |
| FY2022, ended Dec 31, 2022 | $19.7B |
| FY2023, ended Dec 31, 2023 | $20.4B |
| FY2024, ended Dec 31, 2024 | $22.1B |
| FY2025, ended Dec 31, 2025 | $25.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $26.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.18B | $1.66B |
| FY2017, ended Dec 31, 2017 | $1.95B | $1.61B |
| FY2018, ended Dec 31, 2018 | $1.93B | $1.90B |
| FY2019, ended Dec 31, 2019 | $1.67B | $2.06B |
| FY2020, ended Dec 31, 2020 | $1.50B | $1.82B |
| FY2021, ended Dec 31, 2021 | $1.82B | $2.30B |
| FY2022, ended Dec 31, 2022 | $2.24B | $1.73B |
| FY2023, ended Dec 31, 2023 | $2.30B | $1.82B |
| FY2024, ended Dec 31, 2024 | $2.75B | $2.16B |
| FY2025, ended Dec 31, 2025 | $2.71B | $2.82B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.07B | $3.74B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $32.0M |
| FY2017, ended Dec 31, 2017 | $22.0M |
| FY2018, ended Dec 31, 2018 | $61.0M |
| FY2019, ended Dec 31, 2019 | $3.56B |
| FY2020, ended Dec 31, 2020 | $553M |
| FY2021, ended Dec 31, 2021 | $118M |
| FY2022, ended Dec 31, 2022 | $351M |
| FY2023, ended Dec 31, 2023 | $458M |
| FY2024, ended Dec 31, 2024 | $414M |
| FY2025, ended Dec 31, 2025 | $201M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $247M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.31B |
| FY2017, ended Dec 31, 2017 | $9.49B |
| FY2018, ended Dec 31, 2018 | $10.0B |
| FY2019, ended Dec 31, 2019 | $13.5B |
| FY2020, ended Dec 31, 2020 | $13.8B |
| FY2021, ended Dec 31, 2021 | $13.4B |
| FY2022, ended Dec 31, 2022 | $15.0B |
| FY2023, ended Dec 31, 2023 | $16.2B |
| FY2024, ended Dec 31, 2024 | $23.9B |
| FY2025, ended Dec 31, 2025 | $22.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $23.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 9.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 440M |
| FY2017, ended Dec 31, 2017 | 434M |
| FY2018, ended Dec 31, 2018 | 424M |
| FY2019, ended Dec 31, 2019 | 425M |
| FY2020, ended Dec 31, 2020 | 423M |
| FY2021, ended Dec 31, 2021 | 415M |
| FY2022, ended Dec 31, 2022 | 408M |
| FY2023, ended Dec 31, 2023 | 402M |
| FY2024, ended Dec 31, 2024 | 402M |
| FY2025, ended Dec 31, 2025 | 403M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 398M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $725M | $90.0M |
| FY2017, ended Dec 31, 2017 | $750M | $101M |
| FY2018, ended Dec 31, 2018 | $1.00B | $89.0M |
| FY2019, ended Dec 31, 2019 | $248M | $86.0M |
| FY2020, ended Dec 31, 2020 | $402M | $94.0M |
| FY2021, ended Dec 31, 2021 | $1.35B | $108M |
| FY2022, ended Dec 31, 2022 | $1.50B | $84.0M |
| FY2023, ended Dec 31, 2023 | $1.30B | $93.0M |
| FY2024, ended Dec 31, 2024 | $262M | $118M |
| FY2025, ended Dec 31, 2025 | — | $169M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — | $173M |
Valuation
At current price- Market Cap
- $93.8B
- P/E
- 30.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.6×
- Price / Book
- 9.5×
- EV / EBITDA
- 15.0×
Growth
Trailing 12 months- Revenue (TTM)
- $26.1B
- Revenue Growth YoY
- 5.2%
- Revenue CAGR 3Y
- 8.6%
- Revenue CAGR 5Y
- 10.6%
- EPS Growth YoY
- 20.0%
- Net Income Growth YoY
- 19.7%
Profitability
Trailing 12 months- Gross Margin
- 40.4%
- Operating Margin
- 18.4%
- Net Margin
- 11.8%
- FCF Margin
- 14.3%
- Return on Equity
- 31.7%
Earnings
Trailing 12 months- Net Income
- $3.07B
- EPS (diluted)
- $7.62
- EBITDA
- $7.77B
- Operating Income
- $4.80B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $247M
- Total Debt
- $23.4B
- Net Debt
- $23.1B
- Total Assets
- $46.5B
- Total Liabilities
- $36.7B
- Shareholders' Equity
- $9.87B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $6.57B
- Capital Expenditure
- $2.83B
- Free Cash Flow
- $3.74B
Dividends and risk
Last 12 months- Dividend Yield
- 1.6%
- Dividend / Share
- $3.66
- Beta (5Y)
- 0.42
Every ratio is calculated from the company’s reported figures.